Last edition
News about "Eros Carletti "
Syntegon Posts Record Year in 2025 and Aims for Further Growth
Syntegon reports a record 2025 with revenue up 10 percent to €1.75 billion and pharma sales surging 22 percent, alongside strong EBITDA and cash flow growth, reinforcing its position as a key lifecycle partner for pharma, biotech and food industries.
Eros Carletti | 21/04/2026 | By News Bureau | 223
Syntegon Posts Strong Q3 Performance with Accelerating Pharma Growth and Higher Profit Margins
Syntegon recorded double-digit growth in sales and profitability, supported by strong pharma demand, new technology launches, and continued operational improvements.
Eros Carletti | 24/11/2025 | By Dineshwori
Syntegon Welcomes Eros Carletti as New Chief Financial Officer
Eros Carletti succeeds Dr. Peter Hackel, who left Syntegon on December 31, 2024, following two successful years as CFO.
Eros Carletti | 23/01/2025 | By Aishwarya | 426
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy